The Commerce Department published notices in the Federal Register May 28 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):

The International Trade Commission published notices in the May 27 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):

The Commerce Department published notices in the Federal Register May 27 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):

The Commerce Department has published the final results of the antidumping duty administrative review on xanthan gum from China (A-570-985). These final results will be used to set final assessments of AD on importers for subject merchandise entered July 1, 2022, through June 30, 2023.

The Commerce Department is setting new countervailing duty cash deposit requirements for imports of active anode material from China (A-570-195), after finding subsidization of Chinese producers in the preliminary determination of its CVD investigation. Suspension of liquidation and cash deposit requirements will take effect for entries on or after May 28, the date that the preliminary determination is scheduled to be published in the Federal Register.

The International Trade Commission published notices in the May 23 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):

The International Trade Commission began a Section 337 investigation into allegations that Nvidia, Qualcomm, OnePlus Technology and Nothing Technology Limited are importing and selling integrated circuits and electronic devices that infringe patents held by Onesta IP, the ITC said in a notice to be published May 27. Onesta filed the complaint in April and is seeking a limited exclusion order and cease and desist orders against the respondents to bar from entry "certain integrated circuits, electronic devices containing the same, and components thereof" that violate the complainant's patents (see 2504230058).

The International Trade Commission began a Section 337 investigation on allegations that German company Fiagon and U.S. parent company Hemostasis are importing and selling balloon dilation devices that infringe patents held by Entellus Medical, Stryker Corporation, and Stryker Sales, the ITC said in a May 23 notice. Entellus and Stryker filed the complaint in April and are seeking a limited exclusion order and cease and desist orders against the respondents to bar from entry "certain balloon dilation devices, systems, and components thereof" that violate the complainants' patents (see 2504230061).

The Commerce Department published notices in the Federal Register May 23 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):

The Commerce Department slightly increased the antidumping duty rate applicable to some exporters of oil country tubular goods (OCTG) from India (A-533-857), it said in a correction to a notice of final results of the antidumping duty administrative review for the period Sept. 1, 2022, through Aug. 31, 2023, originally published May 13. The agency had set a zero percent AD duty cash deposit rate for Surya Roshni Ltd., but erroneously stated that the “all-others” cash deposit rate was zero percent, it said. That “all-others” cash deposit rate, which applies to all Indian exporters that have never received individual rates for their exports of OCTG from India, should be 0.6%, Commerce said. (See 2505120010 for a summary of the original final results of this review.)